• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Antiemetics Companies

    ID: MRFR/HC/6982-HCR
    110 Pages
    Rahul Gotadki
    October 2025

    Antiemetics are medications designed to prevent or alleviate nausea and vomiting. These drugs are commonly used in various medical conditions, including chemotherapy-induced nausea, postoperative nausea, and motion sickness.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Antiemetics Market

    Antiemetics Key Companies

     


    Latest Antiemetics Companies Update:

    Evoke Pharma's Exclusivity: In April 2022, Evoke Pharma received three-year exclusivity for Gimoti (metoclopramide) nasal spray, providing them a competitive edge in the oral alternative drug segment.


    Acacia Pharmaceutical's FDA Approval: Barhemsys, Acacia Pharmaceutical's antiemetic, received US-FDA approval in February 2022, expanding their product portfolio and addressing a niche market for nausea and vomiting associated with migraine.


    Pfizer's Transdermal Patch Development: In September 2023, Pfizer partnered with Relief Therapeutics to develop a transdermal patch for Aprepitant (Emend), aiming to improve patient compliance and ease of administration for chemotherapy-induced nausea and vomiting.


    Meda Pharmaceuticals' Expansion: Meda Pharmaceuticals acquired Australian pharmaceutical company, Almirall, in January 2023, strengthening their market presence in antiemetics with Almirall's innovative NKTR-105.


    List of Antiemetics Key companies in the market

    • GSK (UK)

    • Merck (US)

    • Sanofi-Aventis (France)

    • Pfizer Inc. (US)

    • Mylan (US)

    • Eli Lilly and Company (US)

    • Johnson & Johnson (US)

    • Baxter International (US)

    • Reddy's Laboratories Inc. (India)